These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30047011)

  • 1. Functional analysis of KCNH2 gene mutations of type 2 long QT syndrome in larval zebrafish using microscopy and electrocardiography.
    Tanaka Y; Hayashi K; Fujino N; Konno T; Tada H; Nakanishi C; Hodatsu A; Tsuda T; Nagata Y; Teramoto R; Yoshida S; Nomura A; Kawashiri MA; Yamagishi M
    Heart Vessels; 2019 Jan; 34(1):159-166. PubMed ID: 30047011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and expression analysis of kcnh2 genes in the zebrafish.
    Leong IU; Skinner JR; Shelling AN; Love DR
    Biochem Biophys Res Commun; 2010 Jun; 396(4):817-24. PubMed ID: 20438705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo cardiac assay to determine the functional consequences of putative long QT syndrome mutations.
    Jou CJ; Barnett SM; Bian JT; Weng HC; Sheng X; Tristani-Firouzi M
    Circ Res; 2013 Mar; 112(5):826-30. PubMed ID: 23303164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.
    Couderc JP; Xia X; Peterson DR; McNitt S; Zhao H; Polonsky S; Moss AJ; Zareba W
    Heart Rhythm; 2011 Jul; 8(7):1036-43. PubMed ID: 21315844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome.
    Grunnet M; Behr ER; Calloe K; Hofman-Bang J; Till J; Christiansen M; McKenna WJ; Olesen SP; Schmitt N
    Heart Rhythm; 2005 Nov; 2(11):1238-49. PubMed ID: 16253915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital long QT syndrome with compound mutations in the KCNH2 gene.
    Bando S; Soeki T; Matsuura T; Niki T; Ise T; Yamaguchi K; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Aiba T; Shimizu W; Sata M
    Heart Vessels; 2014 Jul; 29(4):554-9. PubMed ID: 24057343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intronic mutation causes long QT syndrome.
    Zhang L; Vincent GM; Baralle M; Baralle FE; Anson BD; Benson DW; Whiting B; Timothy KW; Carlquist J; January CT; Keating MT; Splawski I
    J Am Coll Cardiol; 2004 Sep; 44(6):1283-91. PubMed ID: 15364333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
    Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
    PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction.
    Biliczki P; Girmatsion Z; Brandes RP; Harenkamp S; Pitard B; Charpentier F; Hébert TE; Hohnloser SH; Baró I; Nattel S; Ehrlich JR
    Heart Rhythm; 2009 Dec; 6(12):1792-801. PubMed ID: 19959132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
    Barc J; Briec F; Schmitt S; Kyndt F; Le Cunff M; Baron E; Vieyres C; Sacher F; Redon R; Le Caignec C; Le Marec H; Probst V; Schott JJ
    J Am Coll Cardiol; 2011 Jan; 57(1):40-7. PubMed ID: 21185499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].
    Liu WL; Hu DY; Li P; Li CL; Qin XG; Li YT; Li L; Li ZM; Dong W; Qi Y; Wang Q
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):463-6. PubMed ID: 16831322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.
    Crotti L; Lundquist AL; Insolia R; Pedrazzini M; Ferrandi C; De Ferrari GM; Vicentini A; Yang P; Roden DM; George AL; Schwartz PJ
    Circulation; 2005 Aug; 112(9):1251-8. PubMed ID: 16116052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing.
    Muñoz-Esparza C; García-Molina E; Salar-Alcaraz M; Peñafiel-Verdú P; Sánchez-Muñoz JJ; Martínez Sánchez J; Cabañas-Perianes V; Valdés Chávarri M; García Alberola A; Gimeno-Blanes JR
    Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):861-8. PubMed ID: 25819988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in the KCNH2 gene associated with short QT syndrome.
    Sun Y; Quan XQ; Fromme S; Cox RH; Zhang P; Zhang L; Guo D; Guo J; Patel C; Kowey PR; Yan GX
    J Mol Cell Cardiol; 2011 Mar; 50(3):433-41. PubMed ID: 21130771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular properties of C-terminal KCNH2 long QT syndrome mutations: description and divergence from clinical phenotypes.
    Biliczki P; Girmatsion Z; Harenkamp S; Anneken L; Brandes RP; Varro A; Marschall C; Herrera D; Hohnloser SH; Nattel S; Ehrlich JR
    Heart Rhythm; 2008 Aug; 5(8):1159-67. PubMed ID: 18675227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of defective protein trafficking rescues Long-QT syndrome in zebrafish.
    Meder B; Scholz EP; Hassel D; Wolff C; Just S; Berger IM; Patzel E; Karle C; Katus HA; Rottbauer W
    Biochem Biophys Res Commun; 2011 May; 408(2):218-24. PubMed ID: 21458413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome.
    Delisle BP; Slind JK; Kilby JA; Anderson CL; Anson BD; Balijepalli RC; Tester DJ; Ackerman MJ; Kamp TJ; January CT
    Mol Pharmacol; 2005 Jul; 68(1):233-40. PubMed ID: 15851652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
    Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
    BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.